Masters Capital Mgmt »

Denali Therapeutics shares owned by Masters Capital Mgmt

Quarter-by-quarter ownership of Denali Therapeutics (DNLI) shares owned by Masters Capital Mgmt from 13F filings

Historical chart of Masters Capital Mgmt investment in Denali Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Denali Therapeutics held by Masters Capital Mgmt consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Denali Therapeutics by Masters Capital Mgmt

Quarter filed Position value Share count Share price at filing
2025-09-30 $11M 750k 14.52
2025-06-30 $8.4M 600k 13.99

More positions owned by Masters Capital Mgmt

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
International Business Machines Call Option (IBM)
Delta Air Lines Inc Del Com New (DAL)
Eastman Chemical Company (EMN)
Gilead Sciences Call Option (GILD)
United Parcel Service CL B (UPS)
Citigroup Com New Call Option (C)
Corning Incorporated Call Option (GLW)
Fluor Corporation (FLR)
Schlumberger Com Stk Call Option (SLB)
Intel Corporation Call Option (INTC)
Alcoa Call Option (AA)
General Motors Company Call Option (GM)
Archer Daniels Midland Company (ADM)
Bristol Myers Squibb (BMY)

View all positions for Masters Capital Mgmt

Top funds holding Denali Therapeutics

BlackRock
Vanguard Group
Baillie Gifford & Co
FMR
T. Rowe Price Investment Management
Ubs Global Asset Management Americas
State Street Corporation
Temasek Holdings
Capital Research Global Investors
Baker Bros. Advisors
Alliancebernstein
Geode Capital Management
Crestline Management
Holocene Advisors
Point72 Asset Management

View all funds holding Denali Therapeutics